Liquidia

LQDA · NASDAQ

$36.35+$2.22 (+6.50%)TodayMarket closed · Oct 20, 7:44 PM ET

Prev close $34.13

Latest news

NewsOct 14, 1:00 PM ETAvi Kapoor
Nasdaq Dips Over 400 Points; Bank of America Shares Tumble After Q3 Results
NewsOct 14, 10:02 AM ETAvi Kapoor
Bending Spoons, Liquidia, Verastem And Other Big Stocks Moving Higher On Wednesday
NewsOct 14, 8:39 AM ETRishabh Mishra
Stock Market Today: S&P 500, Dow, Nasdaq Futures Gain Even as September Inflation Report Comes In Hotter Than Expected— ASML, AZZ, GME in Focus (UPDATED)
NewsOct 14, 8:02 AM ETNeeraj Jain
Liquidia Settles Bitter Fight With United Therapeutics
Press releaseOct 13, 6:18 PM ETBusiness Wire
LIQUIDIA CORPORATION LQDA INVESTORS: Contact Kirby McInerney LLP About the Firm’s Securities Investigation Following 57.2% Share Drop
Press releaseOct 13, 5:44 PM ETGlobe Newswire
Liquidia Announces Global Settlement Resolving All Pending Litigation with United Therapeutics, Ensuring Continued Commercialization of YUTREPIA in PAH
Press releaseOct 12, 2:55 PM ETPRNewswire
Liquidia Corporation (LQDA) Securities Investigation Notice - Levi & Korsinsky
NewsOct 12, 9:55 AM ETAvi Kapoor
First Tracks Biotherapeutics, C3.ai, CCC Intelligent Solutions And Other Big Stocks Moving Higher On Monday
Press releaseOct 8, 10:18 AM ETGlobe Newswire
Levi & Korsinsky Notifies Investors of Pending Investigation Into Securities Claims Involving Liquidia Corporation (LQDA)
Press releaseOct 7, 10:50 PM ETBusiness Wire
LQDA Investors with $100,000 in Losses Have Opportunity to Join Liquidia Corporation Fraud Investigation with SBS Law
Press releaseOct 7, 4:56 PM ETGlobe Newswire
LIQUIDIA INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating Liquidia Corporation on Behalf of Liquidia Stockholders and Encourages Investors to Contact the Firm
Press releaseOct 6, 3:36 PM ETGlobe Newswire
LIQUIDIA CORPORATION INVESTIGATION: LQDA Securities Investors Encouraged to Contact Kirby McInerney LLP About Their Rights
Press releaseOct 6, 2:39 PM ETPRNewswire
LQDA SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving Liquidia Corporation
Press releaseOct 5, 5:45 PM ETPRNewswire
Liquidia Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into Liquidia (LQDA)
NewsOct 1, 12:03 PM ETHenry Khederian
Liquidia Stock Extends Slide Following US Court Ruling in Patent Dispute
NewsOct 1, 8:05 AM ET
12 Health Care Stocks Moving In Thursday's Pre-Market Session
NewsOct 1, 8:01 AM ETAvi Kapoor
Progress Software, Nft And Other Big Stocks Moving Lower In Thursday’s Pre-Market Session
NewsSep 30, 11:29 PM ETMohd Haider
Why is Liquidia (LQDA) Stock Trending After Hours?
Press releaseSep 30, 1:20 PM ETGlobe Newswire
Liquidia Provides Update on Hatch-Waxman Litigation Tied to ‘327 Patent
NewsSep 24, 1:35 PM ET
10 Health Care Stocks Whale Activity In Today’s Session
NewsSep 3, 10:41 AM ETVandana Singh
FDA Fast-Tracks Liquidia Drug for Painful Systemic Sclerosis Complication
NewsSep 3, 7:31 AM ET
Liquidia Receives FDA's Fast Track Designation For YUTREPIA Inhalation Powder To Treat Raynaud's Phenomenon Associated With Systemic Sclerosis
Press releaseSep 3, 7:30 AM ETGlobe Newswire
FDA Grants Fast Track Designation to YUTREPIA® for the Treatment of Raynaud's Phenomenon Associated with Systemic Sclerosis
NewsAug 12, 6:39 AM ET
Liquidia Q2 EPS $0.74 Beats $0.41 Estimate, Sales $171.679M Beat $116.675M Estimate
Press releaseAug 12, 6:30 AM ETGlobe Newswire
Liquidia Corporation Reports Second Quarter 2026 Financial Results
NewsJun 26, 4:35 AM ET
Transcript: Liquidia Q1 2026 Earnings Conference Call
Press releaseJun 5, 7:25 PM ETPRNewswire
Marvell Technology and Flex Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600
Press releaseMay 11, 6:30 AM ETGlobe Newswire
Liquidia Corporation Reports First Quarter 2026 Financial Results
NewsMay 6, 1:35 PM ET
10 Health Care Stocks Whale Activity In Today's Session
Press releaseMar 5, 6:30 AM ETGlobe Newswire
Liquidia Corporation Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
NewsMar 4, 10:02 AM ET
A Peek at Liquidia's Future Earnings
NewsJan 16, 12:35 PM ET
10 Health Care Stocks With Whale Alerts In Today's Session
NewsJan 9, 12:35 PM ET
10 Health Care Stocks Whale Activity In Today's Session
NewsJan 9, 6:33 AM ET
Liquidia Posts $148.3M In 2025 And $90.1M In Q4 YUTREPIA Sales, Sees Strong Momentum Into 2026
Press releaseJan 9, 6:30 AM ETGlobe Newswire
Liquidia Corporation Announces Preliminary Full-Year 2025 YUTREPIA Net Sales and Corporate Update
NewsJan 2, 12:23 PM ETAvi Kapoor
Why Intelligent Bio Solutions Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Friday's Mid-Day Session
NewsNov 3, 7:05 AM ET
12 Health Care Stocks Moving In Monday's Pre-Market Session
NewsOct 31, 12:03 PM ET
What's Next: Liquidia's Earnings Preview
NewsOct 6, 8:02 AM ET
What 5 Analyst Ratings Have To Say About Liquidia
NewsAug 12, 8:08 AM ET
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
NewsAug 11, 11:04 AM ET
Earnings Preview For Liquidia
Press releaseJun 23, 4:34 PM ETGlobe Newswire
Liquidia Receives $50 Million from Healthcare Royalty (HCRx) Following First Commercial Sale of YUTREPIA™
NewsJun 10, 1:59 PM ETAvi Kapoor
Dow Gains 50 Points; US Small Business Optimism Index Rises In May
NewsMay 28, 11:08 AM ETAvi Kapoor
These Analysts Boost Their Forecasts On Liquidia
NewsMay 28, 9:00 AM ET
Breaking Down Liquidia: 12 Analysts Share Their Views

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.

Latest news

Nasdaq Dips Over 400 Points; Bank of America Shares Tumble After Q3 Results

Bending Spoons, Liquidia, Verastem And Other Big Stocks Moving Higher On Wednesday

Stock Market Today: S&P 500, Dow, Nasdaq Futures Gain Even as September Inflation Report Comes In Hotter Than Expected— ASML, AZZ, GME in Focus (UPDATED)

Liquidia Settles Bitter Fight With United Therapeutics

LIQUIDIA CORPORATION LQDA INVESTORS: Contact Kirby McInerney LLP About the Firm’s Securities Investigation Following 57.2% Share Drop

Liquidia Announces Global Settlement Resolving All Pending Litigation with United Therapeutics, Ensuring Continued Commercialization of YUTREPIA in PAH

Liquidia Corporation (LQDA) Securities Investigation Notice - Levi & Korsinsky

First Tracks Biotherapeutics, C3.ai, CCC Intelligent Solutions And Other Big Stocks Moving Higher On Monday

Levi & Korsinsky Notifies Investors of Pending Investigation Into Securities Claims Involving Liquidia Corporation (LQDA)

LQDA Investors with $100,000 in Losses Have Opportunity to Join Liquidia Corporation Fraud Investigation with SBS Law

LIQUIDIA INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating Liquidia Corporation on Behalf of Liquidia Stockholders and Encourages Investors to Contact the Firm

LIQUIDIA CORPORATION INVESTIGATION: LQDA Securities Investors Encouraged to Contact Kirby McInerney LLP About Their Rights

LQDA SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving Liquidia Corporation

Liquidia Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into Liquidia (LQDA)

Liquidia Stock Extends Slide Following US Court Ruling in Patent Dispute

12 Health Care Stocks Moving In Thursday's Pre-Market Session

Progress Software, Nft And Other Big Stocks Moving Lower In Thursday’s Pre-Market Session

Why is Liquidia (LQDA) Stock Trending After Hours?

Liquidia Provides Update on Hatch-Waxman Litigation Tied to ‘327 Patent

10 Health Care Stocks Whale Activity In Today’s Session

FDA Fast-Tracks Liquidia Drug for Painful Systemic Sclerosis Complication

Liquidia Receives FDA's Fast Track Designation For YUTREPIA Inhalation Powder To Treat Raynaud's Phenomenon Associated With Systemic Sclerosis

FDA Grants Fast Track Designation to YUTREPIA® for the Treatment of Raynaud's Phenomenon Associated with Systemic Sclerosis

Liquidia Q2 EPS $0.74 Beats $0.41 Estimate, Sales $171.679M Beat $116.675M Estimate

Liquidia Corporation Reports Second Quarter 2026 Financial Results

Transcript: Liquidia Q1 2026 Earnings Conference Call

Marvell Technology and Flex Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600

Liquidia Corporation Reports First Quarter 2026 Financial Results

10 Health Care Stocks Whale Activity In Today's Session

Liquidia Corporation Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

A Peek at Liquidia's Future Earnings

10 Health Care Stocks With Whale Alerts In Today's Session

10 Health Care Stocks Whale Activity In Today's Session

Liquidia Posts $148.3M In 2025 And $90.1M In Q4 YUTREPIA Sales, Sees Strong Momentum Into 2026

Liquidia Corporation Announces Preliminary Full-Year 2025 YUTREPIA Net Sales and Corporate Update

Why Intelligent Bio Solutions Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Friday's Mid-Day Session

12 Health Care Stocks Moving In Monday's Pre-Market Session

What's Next: Liquidia's Earnings Preview

What 5 Analyst Ratings Have To Say About Liquidia

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

Earnings Preview For Liquidia

Liquidia Receives $50 Million from Healthcare Royalty (HCRx) Following First Commercial Sale of YUTREPIA™

Dow Gains 50 Points; US Small Business Optimism Index Rises In May

These Analysts Boost Their Forecasts On Liquidia

Breaking Down Liquidia: 12 Analysts Share Their Views